Cargando…

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

Epstein-Barr virus (EBV) is associated with a number of different human tumors and appears to play different pathogenetic roles in each case. Thus, immunoblastic B cell lymphomas of the immunosuppressed display the full pattern of EBV latent gene expression (expressing Epstein-Barr nuclear antigen [...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1993
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190903/ https://www.ncbi.nlm.nih.gov/pubmed/8381153

Ejemplares similares

Host genetics of Epstein–Barr virus infection, latency and disease
por: Houldcroft, Charlotte J, et al.
Publicado: (2015)

B cell activation and the establishment of Epstein-Barr virus latency
Publicado: (1988)

Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
por: Messinger, Joshua E., et al.
Publicado: (2019)

Epstein-Barr virus and the origin of Hodgkin lymphoma
por: Vockerodt, Martina, et al.
Publicado: (2014)

Epstein Barr Virus-Associated Hodgkin Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2018)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma
por: Lorenzetti, Mario A., et al.
Publicado: (2010)

Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis
por: Burton, Eric M., et al.
Publicado: (2022)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.
por: Mueller, N.
Publicado: (1987)

Epstein-Barr virus-associated Hodgkin's disease following renal transplantation
por: Choi, Jung-Hye, et al.
Publicado: (2006)

Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Begić, Valerija, et al.
Publicado: (2022)

Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.
por: Armstrong, A. A., et al.
Publicado: (1998)

Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
por: Sugiura, M., et al.
Publicado: (1996)

Discussion of Epidemiologic Studies Assessing the Role of the Epstein-Barr Virus in Hodgkin's Disease
por: Grufferman, Seymour
Publicado: (1987)

Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018)

Epstein-Barr virus latency switch in human B-cells: a physico-chemical model
por: Werner, Maria, et al.
Publicado: (2007)

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma
por: Sarwari, Nawid M., et al.
Publicado: (2016)

Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis
por: Casiraghi, Costanza, et al.
Publicado: (2012)

Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
por: Bentz, Gretchen L., et al.
Publicado: (2019)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

Effect of material deprivation on Epstein–Barr virus infection in Hodgkin's disease in the West Midlands
por: Flavell, K, et al.
Publicado: (1999)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

EPSTEIN-BARR VIRUS-NEGATIVE HUMAN MALIGNANT T-CELL LINES
por: Kaplan, Joseph, et al.
Publicado: (1974)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Molecular Genetics in Epstein–Barr Virus-Associated Malignancies
por: Umakanthan, Srikanth, et al.
Publicado: (2021)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Hemophagocytic Lymphohistiocytosis in a Patient with Hodgkin Lymphoma, HIV, and Epstein-Barr Virus
por: Javed, Faiza, et al.
Publicado: (2023)

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2019)

Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin’s Lymphoma
por: Leonard, Sarah, et al.
Publicado: (2012)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
por: Ghosh, Sajal K., et al.
Publicado: (2012)

STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency
por: Wang, Yuyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpd56mbpjjj2konr2vpblq97gh